Trial NCT02495454

View at ClinicalTrials.gov 
Org. Study IDs: FIL_GAEL
Secondary IDs: 2014-005697-10

Last trial update was posted on 2020-11-05

MeSH Interventions

Obinutuzumab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin

Other Conditions

CD20 Positive Diffuse Large B-cell Lymphoma Elderly Unfit Patients

Stopping Reasons

Primary objective not obtained after interim analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID